Xiang Li

Xiang (Sean) Li, CTO & Co-Founder, is a technology executive experienced at building and leading technical teams with expertise in clinical bioinformatics, data science, and software engineering. Dr. Li has a strong track record of delivering results by developing big-picture product strategies and following up with methodical execution. Previously, he was the Vice President of Clinical Bioinformatics at Pathway Genomics. Prior to that, he was the Director of Bioinformatics Development at Ambry Genetics where he led the implementation of the first commercial clinical exome sequencing test in 2011 and hereditary cancer panels based on next-gen sequencing. Dr. Li received his doctoral degrees in Bioinformatics from the University of Illinois, Chicago.